chrisvoncsefalvay/vaers-outcomes huggingface dataset:
achiness for half of a day; he felt tiredness; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (achiness for half of a day) and FATIGUE (he felt tiredness) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A. and 026L20A.) for COVID-19 vaccination.     Concurrent medical conditions included Joint injury (Joint injuries). Concomitant products included MULTIVITAMINS [VITAMINS NOS] from 01-Jan-2000 to an unknown date for an unknown indication.   On 08-Jan-2021 at 1:40 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021 at 1:42 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced PAIN (achiness for half of a day). 03-Feb-2021, the patient experienced FATIGUE (he felt tiredness). On 04-Feb-2021, PAIN (achiness for half of a day) and FATIGUE (he felt tiredness) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   In concomitant medications GNC Joint supplement was also reported. No treatment details were reported.  Company Comment - This case concerns a 39 year old male patient with concurrent medical condition of joint injury, who experienced the non-serious unexpected event of pain and the expected event fatigue. The events occurred on the same day after receiving the second dose of mRNA-1273 vaccine. The rechallenge was not applicable. Patient's concurrent condition of joint injury remains a confounder. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2021-402807 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Dec-2021: Concomitant medication, anatomical location, time of suspect and patient details (height, weight and race) were added. On 10-Dec-2021: Follow up received: Outcome of event updated; Sender's Comments: This case concerns a 39 year old male patient with concurrent medical condition of joint injury, who experienced the non-serious unexpected event of pain and the expected event fatigue. The events occurred on the same day after receiving the second dose of mRNA-1273 vaccine. The rechallenge was not applicable. Patient's concurrent condition of joint injury remains a confounder. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.
First / vaccine on October 19, 2020 and never received the second; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 19th October 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided are as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not received the 2nd dose of Shingrix, which led to incomplete course of vaccination. The caller refused to provide demographics or answer questions concerning adverse event details. No batch number or expiration date were provided for 1st dose. Did not consent to follow-up.
Patient c/o dizziness. Assessed by EMS. V/S taken.  patient in stable condition. no hospitalization needed. sent home.
Patient experienced a syncope episode with lightheadedness, feeling faint and vision closing in. She was very nervous before the vaccination. 15 minutes post vaccine she developed a rash on her inner crook of her elbows and forearms, face and legs. Patient states she experiences these rashes when under extreme stress or heat conditions such as final exams, long distance running track or hot tubs. She did not experience any tingling or swelling of the face lips or tongue. She was observed in pharmacy for 1 hour and rash dissipated. Patient states that most of the rash had gone away once she got home approximately 90 minutes after vaccination.
Leg is weak; Arm is sore; Can barely lift arm; Leg is numb; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Leg is weak), PAIN IN EXTREMITY (Arm is sore), MOBILITY DECREASED (Can barely lift arm) and HYPOAESTHESIA (Leg is numb) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced MUSCULAR WEAKNESS (Leg is weak), PAIN IN EXTREMITY (Arm is sore), MOBILITY DECREASED (Can barely lift arm) and HYPOAESTHESIA (Leg is numb). At the time of the report, MUSCULAR WEAKNESS (Leg is weak), PAIN IN EXTREMITY (Arm is sore), MOBILITY DECREASED (Can barely lift arm) and HYPOAESTHESIA (Leg is numb) outcome was unknown.            The patient had circulation problems; however, she was not taking medication regularly.  No concomitant medications were reported   No treatment information was provided.  She was having problems with her right side.
Not feeling good; Whole world turned upside down for couple of day; diarrhea; dizziness; fast heart beat; eyes burning; ears hurting; could not stand up; difficulty breathing; stomach hurts; feeling sick; Hyperventilating; Fatigue; muscle pain; Bad headaches; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Not feeling good), FEELING ABNORMAL (Whole world turned upside down for couple of day), DIARRHOEA (diarrhea), DIZZINESS (dizziness) and HEART RATE INCREASED (fast heart beat) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced FEELING ABNORMAL (Not feeling good), FEELING ABNORMAL (Whole world turned upside down for couple of day), DIARRHOEA (diarrhea), DIZZINESS (dizziness), HEART RATE INCREASED (fast heart beat), EYE IRRITATION (eyes burning), EAR PAIN (ears hurting), HYPOKINESIA (could not stand up), DYSPNOEA (difficulty breathing), ABDOMINAL PAIN UPPER (stomach hurts), MALAISE (feeling sick), HYPERVENTILATION (Hyperventilating), FATIGUE (Fatigue), MYALGIA (muscle pain), HEADACHE (Bad headaches) and VOMITING (vomiting). At the time of the report, FEELING ABNORMAL (Not feeling good), FEELING ABNORMAL (Whole world turned upside down for couple of day), DIARRHOEA (diarrhea), DIZZINESS (dizziness), HEART RATE INCREASED (fast heart beat), EYE IRRITATION (eyes burning), EAR PAIN (ears hurting), HYPOKINESIA (could not stand up), DYSPNOEA (difficulty breathing), ABDOMINAL PAIN UPPER (stomach hurts), MALAISE (feeling sick), HYPERVENTILATION (Hyperventilating), FATIGUE (Fatigue), MYALGIA (muscle pain), HEADACHE (Bad headaches) and VOMITING (vomiting) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant medication not provided. Treatment information not provided.
I got a rash in my back after 2 weeks after I took my vaccine. With the help of steroids it went away, and came now in December, which is several months after it went away. I also contracted COVID sometime after the vaccine, and according to my eye doctor my vision is a lot worse then what it was the last time I had a check up in March. I now am developing knee issues in the morning when I wake up, and not sure if it is related to the vaccine or age, however the eye problems are concerning since my husband is all the sudden experiencing eye problems as well. My eye doctor also is shocked in how much my eyes are deteriorating..
Red itchy rash with firmness at the injection site (occurred 5 days after vaccination). Sore Arm
-1/30 (Sun): I had a low-grade fever and was sweating 12 hours after receiving my booster shot (at 2:15 Pm), but these symptoms were similar to the ones I experienced when I got the first 2 doses. These symptoms lasted for approx. 24 hours.  - 2/2 (Wed): I started seeing skin discoloration on my left leg that did not disappear after a day.  - 2/5 (Sat): I started noticing visible blood vessels on my chest and my face - 2/6 (Sun): I started seeing skin discoloration on my face - 2/16 (Wed):  I started seeing skin discoloration on my chest
High fever to "105.0 F" per mom 11-7-09. Seen at emergency room 11-8-09 (evening). Work-up essentially -. Fever resolved.
40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients).    This case contains information for the 28th of 40 adult patients. Concomitant medication was not provided. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-698650.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-698650:Master case
Headache, Myalgia, NauseaVomiting,  fatigue site pain redness swelling both doses Narrative:
Gave Td vs. Tdap needed to prevent pertussis in unborn child. Client was 29 weeks when vaccine was given. Her due date is Jan. 10 of 2018. No reported S/S R/T vaccination. Will contact client to receive Tdap before 36 weeks of Gestation as directed by supervisor.
swelling & redness size of an orange on rt arm (gets larger @ noc) temp goes up to 101 ax-controlled by APAP; c/o bones aching; referred to pvt MD for eval of sx;
Expired vaccine was stored in refrigerator on 07-Jun-2022 and was administered on 08-Jun-2022; No adverse event; Patient received vaccine that was expired and past the Manufacturers expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator on 07-Jun-2022 and was administered on 08-Jun-2022), EXPIRED PRODUCT ADMINISTERED (Patient received vaccine that was expired and past the Manufacturers expiration date) and NO ADVERSE EVENT (No adverse event) in a 51-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033K21-2A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jun-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jun-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine that was expired and past the Manufacturers expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator on 07-Jun-2022 and was administered on 08-Jun-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator on 07-Jun-2022 and was administered on 08-Jun-2022), EXPIRED PRODUCT ADMINISTERED (Patient received vaccine that was expired and past the Manufacturers expiration date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT STORAGE ERROR (Expired vaccine was stored in refrigerator on 07-Jun-2022 and was administered on 08-Jun-2022) and EXPIRED PRODUCT ADMINISTERED (Patient received vaccine that was expired and past the Manufacturers expiration date).    No concomitant medications were reported.  Vaccine was initially stored in refrigerator on 07-Jun-2022.  The vial did not undergone any temperature excursion issue.  The reporter thought that previously, the reporter saw that the expiration date of the vial was 20-Jun-2022 when the reporter looked up to it but however, the reporter had nothing in writing or printed to confirm the expiration date of 20-Jun-2022 for the vial.  On 08-Jun-2022, the patient received booster dose of Moderna COVID-19 vaccine.  No adverse events were reported by the reporter.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2022: Live follow up received contains updated suspect product dose details (added dose regimens) and an updated narrative On 02-Sep-2022: Follow up received included no new information.
Patient received MMR on 3/7/2019 instead of MMR-V as ordered. Patient not immunized with Varicella vaccine on this date. Varicella was given on 6/18/19 as the catch up dose. No Varicella outbreak reported during lack of coverage.
The Moderna COVID-19 Vaccine is only FDA authorized by EUA for patients 18 years of age or older; however, this vaccine was given to a 17 year old in mistake. The patient was contacted and notified. She had no adverse reactions. The prescriber was also notified and said it was acceptable. Patient will still receive second dose of Moderna per protocol.
About 4 hours after being injected with the vaccine, I was sitting down eating lunch. I noticed an acuteness to my tinnitus. I'd say, there has always been a low hum, but it was suddenly a million crickets. I had to stop and figure out where this noise was coming from, but it was just my ears ringing that bad. There were vents in the cafeteria so I wasn't sure if it was those or something but it was like a switch that just turned on. I was hoping that it would just go away and spoke to my doctor about it. I started to panic because they required you to have both vaccinations for my job. I just noticed after a period of time that my tinnitus got worse after COVID and the first vaccine. My tinnitus is constant but not that bad. Once I got the vaccine, I was scared that it would be worse after the second one. I fought about it because I didn't want it to get worse. I talked to my doctor about it and my doctor works for (Privacy). I went to ENT and he also works for (Privacy). They gave me hearing tests as well and I don't have bad hearing. (Privacy) wasn't allowing ENT issues to exclude from the vaccination. I got the next vaccine, and it didn't get worse, but it hasn't gone away. I'm not sure if its permanent now. I'm just hoping that it goes back to the way it was before.
06/02/11 Got varicella and MMR vaccine on 5/12/11, started showing bumps on 5/20/11. Was seen on 5/23/11 for the reaction here at occupational health. Patient is back today because bumps are getting worst, bigger and wider.
Patient was leaving room and at front desk the secretary noticed the patients lips turning white.  Mom then picked patient up and brought him into an exam room to be monitored.  Patient was placed on a table lying down with legs up at 45 degree and regained color to lips and alertness within 5 minutes.  NO LOC or confusion or any impairment to past present or future memory.
Patient received Fluzone high dose on 10/27/20. By the time patient returned home (approx. 20minutes) pt. felt fever and chills and stomach ache. Patient went to bed early due to symptoms and woke up later that night feeling stiffness in face. When he looked in mirror, he saw face was very swollen and red hot. Both eyes were swollen shut. He called doctor on Thursday 10/29/20 and was prescribed Medrol dosepak. Sunday 11/1/20 patient call pharmacy to say dosepak was slow in taking effect and he was starting to itch and face  was scaly. I recommended he talk to doctor and buy Benadryl. Today, Monday 11/2/20 patient states skin around eyes is scaly and peels easily. Scalp is painful to the touch and left ear is swollen like cauliflower and very hot. Vision is good and breathing not affected. Patient is waitng for MD to return his call.
10:30 am - Vaccine given, client reports dizziness. Instructed client to remain seated, glass of water given. 10:45 - Client states "I'm ok" & leaves room. Nurse finds client pale & dizzy. Instructs client to lay down on exam table. BP taken. NP assesses client, BP taken q 5 mins. 11:00am NP reports client stable. Client eats crackers and reports "feeling better". Client leaves office.
Second menstruation one week after ending normal menses; Headache; Exhaustion; Stomach ache; Diarrhea; Leg cramps; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 20Apr2021 at 10:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included oral lichen planus and allergy to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included alprazolam (XANAX) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 30Mar2021 at 16:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient previously took omeprazole (PRILOSEC) and codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 23Apr2021, the patient had second menstruation one week after ending normal menses and commencing 3 days after second dose. On an unknown date in Apr2021, the patient experienced leg cramps, headache, exhaustion, stomach ache and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event second menstruation one week after ending normal menses was resolved on 28Apr2021, after the duration of 5 days. The clinical outcome of the events headache, exhaustion, stomach ache and diarrhea was resolved on an unknown date in Apr2021, after the duration of 2 days. The clinical outcome of the event leg cramps was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Irritable, Vomiting, and Blood in stool started 10/9, to ER  10/12. Diagnosed with intusseseption. 10/22/2008 MR received for DOS 10/12-13/2008 with DX: Intussusception. Infant presented to ER with several day hx of vomiting/diarrhea, blood in stool and abdominal pain.  Poor PO intake. PE (+) for distended, tender abdomen. R sided abd mass noted by ped surgeon. Dx with IS which was reduced by Barium Enema. Observed o/n.
Fainted, fell and hit nose on chair -small abrasion on nose and bleeding from nares (elevated legs, ice pack to nose). Client was sent to ER with mother and siblings.
Dyspnea, blurred vision, euphoria, peripherial extremity numbness.  Treated with O2, Benadryl 50mg IM
Experienced dec appetite less than 24 hrs following inject, pt had red rash on both legs fr thigh to knee;
Pt is reporting arm pain after immunization, is especially worried about higher site (containing FLUZONE HB, PNEUMOVAX 23 was below it), and reported it to pharmacy after reading report on the internet about possible joint damage. Encouraged pt to ice arm for 20 minute intervals and try keep using arm to help work out the stiffness more quickly. Will follow up to see how pt's arm pain is improving. Will encourage a visit with physician if not improving.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 69-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Dec2021 as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "In remission from mucosal melanoma" (unspecified if ongoing); "Known allergies: Sulfa drugs" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Doxycycline, reaction(s): "Allergy". The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were not taken as a result of covid-19, drug ineffective.  Antiviral details: Product: COVID 19 Treatment, brand: Paxlovid, Treatment start date: 28May2022 and stop date: 01Jun2022, indication is used for treatment of COVID-19, Administrator route: Oral. The patient did not receive other medication in 2 weeks. The patient experienced adverse event on 07Jun2022 Routine monthly labs done post cancer treatment were done on 07Jun22 and the ALK was elevated (134). The outcome of events was not recovered. The patient did not receive treatment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
To this date my injection area is visible, about a quarter in size. Skin is rougher then normal skin ( chicken skin) Area is extremely itchy.
A short while (20 minutes) after the flu shot (high dose FLUZONE 2018-19 SYR) was administered I experienced strange pain sensation in my hip joints, back of my neck, and shoulders. Within an hour I experienced extreme chills and nausea. This led to rounds of vomiting over the next 2 hours. At the end I fell asleep and slept for close to 10 hours.